Hematopoietic stem cell transplantation (HSCT) is an established therapeutic strategy for the
treatment of malignant (leukemia and lymphoma) and non-malignant (thalassemia, anemia …

Hematopoietic cell transplantation (HCT) refers to 2 distinct therapies from 2 distinct
transplant sources: autologous (self) and allogeneic (non-self). Autologous HCT can be …

Acute kidney injury (AKI) is a common adverse event after hematopoietic cell transplantation
(HCT). AKI is associated with early death or chronic kidney disease among transplant …

Allogeneic hematopoietic cell transplantation (HCT) offers cure for some patients with
hematological diseases but is associated with significant risk of morbidity and mortality. We …

Background Previous reports have shown that acute kidney injury (AKI) is common after
hematopoietic stem cell transplantation (HSCT), which is a crucial treatment for patients with …

Acute kidney injury (AKI) is nearly universally associated with worse outcomes, especially
among children after hematopoietic stem cell transplant (HCT). Our objective was to …

Purpose Cryptosporidium parvum is a protozoan parasite infecting most mammalian hosts
and causing major health issues. The present study investigated the efficacy of ginger …

Background Sepsis disproportionately affects allogeneic hematopoietic cell transplant (HCT)
recipients and is challenging to define. Clinical criteria that predict mortality and intensive …

Neurologic complications are common after solid-organ transplantation, occurring in one-
third of patients. Immunosuppression-related neurotoxicity (involving calcineurin inhibitors …

Background The main purpose of our study was to evaluate the ability of renal functional
reserve (RFR) to stratify the risk of acute kidney injury (AKI) occurrence within 100 days of …